VRTX
#112
Vertex Pharmaceuticals Incorporated - Common Stock
541.6 9 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.07%
Variación mensual
+14.26%
Variación en los últimos 6 meses
+9.29%
Cambio anual
+38.53%
Cierres anteriores
547.5 5
Open
541.6 9
Mínimo
541.6 9
Máximo
541.6 9
Volumen
298
Financials
- Market Capitalization 137.3 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
29.59
Relación precio/flujo de caja
9.75
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 208 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 794.19 USD | -1.67% | -4.83% | +13.46% | +36.80% | 81.77 B USD | ||
| 263 |  ARGX argenx SE - American Depositary Shares | 1023.21 USD | -3.37% | -0.01% | +18.84% | +43.71% | 63.32 B USD | ||
| 296 |  MRNA Moderna, Inc. - Common Stock | 137.99 USD | -3.35% | -3.30% | +146.94% | +476.64% | 55.09 B USD | ||
| 351 |  RVMD Revolution Medicines, Inc. - Common Stock | 207.88 USD | -6.00% | -0.57% | +13.25% | +275.23% | 44.56 B USD |